September 22, 2025 at 02:40PM Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment Public Meeting - 09/24/2025

The Food and Drug Administration (FDA) is holding a hybrid public meeting titled "Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment on 9/24/2025.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8E51FI2